Vasculitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2021-11-12
First-in-class medicine recommended for treatment of rare blood vessel inflammation
EMA recommends first-in-class medicine for treatment of a rare blood vessel inflammation, signaling a potential new option for patients with…